The role of conventional and functional endorectal magnetic resonance imaging in the decision of whether to preserve or resect the neurovascular bundles during radical retropubic prostatectomy

References

• Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981–2001. Semin Urol Oncol 2002; 20: 3–9
   PubMedGoogle Scholar
• Singer PA, Tasch ES, Stocking C, Rubin S, Siegler M, Weichselbaum R. Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol 1991; 9: 328–34
   PubMed Web of Science ®Google Scholar
• D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE, Wein A. Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure. Urology 1997; 49(3A Suppl)23–30
   PubMed Web of Science ®Google Scholar
• Hersh MR, Knapp EL, Choi J. Newer imaging modalities to assess tumour in the prostate. Cancer Control 2004; 11: 353–7
   PubMedGoogle Scholar
• Coakely FV, Hricak H. Radiologic anatomy of the prostate gland: a clinical approach. Radiol Clin North Am 2000; 38: 15–30
   PubMed Web of Science ®Google Scholar
• McLaughlin PW, Troyer S, Berri S, Narayana V, Meirowitz A, Roberson PL, Montie J. Functional anatomy of the prostate: implications for treatment planning. Int J Radiat Oncol Biol Phys 2005; 63: 479–91
   PubMed Web of Science ®Google Scholar
• Engelbrecht MR, Barentsz JO, Jager GJ, van der Graaf M, Heerschap A, Sedelaar JP, et al. Prostate cancer staging using imaging. BJU Int 2000; 86(Suppl 1)123–34
   PubMed Web of Science ®Google Scholar
• Ogura K, Maekawa S, Okubo K, Aoki Y, Okada T, Oda K, et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 2001; 57: 721–6
   PubMed Web of Science ®Google Scholar
• Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997; 202: 697–702
   PubMed Web of Science ®Google Scholar
• Hricak H, Wang L, Wei DC, Coakley FV, Akin O, Reuter VE, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004; 100: 2655–63
   PubMed Web of Science ®Google Scholar
• Perrotti M, Kaufman RP, Jr, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HA. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?. J Urol 1996; 156: 106–9
   PubMed Web of Science ®Google Scholar
• D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE, Wein A. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol 1996; 14: 1770–7
   PubMed Web of Science ®Google Scholar
• Huch Boni RA, Boner JA, Debatin JF, Trinkler F, Knonagel H, Von Hochstetter A, et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 1995; 50: 593–600
   PubMed Web of Science ®Google Scholar
• Brown G, Macvicar DA, Ayton V, Husband JE. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 1995; 50: 601–6
   PubMed Web of Science ®Google Scholar
• Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997; 203: 645–52
   PubMed Web of Science ®Google Scholar
• Chandra RV, Heinze S, Dowling R, Shadbolt C, Costello A, Pedersen J. Endorectal magnetic resonance imaging staging of prostate cancer. ANZ J Surg 2007; 77: 860–5
   PubMed Web of Science ®Google Scholar
• Cornud F, Flam T, Chauveinc L, Hamida K, Chrétien Y, Viellefond A, et al. Extraprostatic spread of clinically localised prostate cancer: factors predictive of pT3 tumour and positive endorectal MR imaging examination results. Radiology 2002; 224: 203–10
   PubMed Web of Science ®Google Scholar
• Wang L, Mullerad M, Chen H-N, Eberhardt S, Kattan MW, Scardino PT, Hricak H. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 2004; 232: 133–9
   PubMed Web of Science ®Google Scholar
• Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency: results using a new nerve sparing technique. Br J Urol 1984; 56: 694–7
   PubMedGoogle Scholar
• Cangiano TG, Litwin MS, Naitoh J, Dorey F, deKernion JB. Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. J Urol 1999; 162: 655–8
   PubMed Web of Science ®Google Scholar
• Geary ES, Dendinger TE, Freiha FS, Stamey TA. Nerve sparing radical prostatectomy: a different view. J Urol 1995; 154: 145–9
   PubMed Web of Science ®Google Scholar
• Litwin MS, McGuigan KA, Shpall AI, Dhanani N. Recovery of health related quality of life in the year after radical prostatectomy: early experience. J Urol 1999; 161: 515–9
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129–35
   PubMed Web of Science ®Google Scholar
• Walsh PC, Donker PJ. Impotence following radical prostatectomy: insights into etiology and prevention. J Urol 1992; 128: 492–7
   Web of Science ®Google Scholar
• Sofer M, Hamilton-Nelson KL, Schlesselman JJ, Soloway MS. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol 2002; 20: 1853–8
   PubMed Web of Science ®Google Scholar
• Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150: 110–4
   PubMed Web of Science ®Google Scholar
• Sanwick JM, Dalkin BL, Nagle RB. Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery. Urology 1998 Nov; 52(5)814–8
   PubMed Web of Science ®Google Scholar
• Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395–400
   PubMed Web of Science ®Google Scholar
• Sokoloff MH, Brendler CB. Indications and contraindications for nerve-sparing radical prostatectomy. Urol Clin North Am 2001; 28: 535–43
   PubMed Web of Science ®Google Scholar
• Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 1(71)3582–93
   Web of Science ®Google Scholar
• Lee SE, Hong SK, Han JH, Han BK, Yu JH, Jeong SJ, et al. Significance of neurovascular bundle formation observed on preoperative magnetic resonance imaging regarding postoperative erectile function after nerve-sparing radical retropubic prostatectomy. Urology 2007; 69: 510–4
   PubMed Web of Science ®Google Scholar